DEFINITIVE PROXY STATEMENT

Company

Armata Pharmaceuticals, Inc.

Filed

March 24, 1997

Period of Report

March 24, 1997

Accession Number

0000891020-97-000391

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →